The Institute of Safe Medication Practices (ISMP) has released the 2015 Annual QuarterWatch drug safety report, providing an overview of domestic drug-related adverse events as submitted to the U.S. Food and Drug Administration (FDA) in 2014. In it, the ISMP considered the high number of Lipitor diabetes lawsuits that have accumulated and what they may indicate about the safety of statins like Lipitor.
Lipitor ...
continue reading...